TDS Pregabalin Capsule 75 mg
Pregabalin 75mg
Hard capsule · Prescription medication
TDS Pharm Co., Ltd.
MFDS item code 201907840 · Approved 2019.11.08
This product's status changed to Expired on 2024.11.08. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of neuropathic pain and fibromyalgia; adjunctive treatment of partial seizures in epilepsy
This medication is used for the treatment of peripheral and central neuropathic pain in adults. It also serves as an adjunctive therapy for patients with epilepsy experiencing partial seizures. It is effective in alleviating pain associated with fibromyalgia. Thus, it is effective for various neurological disorders and helps improve the quality of life of patients.
Administer the total daily dose of this medicine, as pregabalin, orally in 2 divided doses, with or without food. This medicine is primarily excreted by the kidneys; therefore, the dose should be adjusted in patients with impaired renal function (see “5. Patients with Renal Impairment”). 1. Neuropathic pain 1) Peripheral neuropathic pain Adults: This medicine may be administered at an initial dose of 150 mg daily. Based on the individual patient's response and tolerability, the dose may be increased to 300 mg daily after 3 to 7 days. If necessary, it may thereafter be increased at 7-day intervals to a maximum of 600 mg daily. 2) Central neuropathic pain Adults: This medicine may be administered at an initial dose of 150 mg daily. Based on the individual patient's response and tolerability, the dose may be increased to 300 mg daily after 1 week. After an additional week, it may be increased to the target daily dose of 600 mg. If the target daily dose is not tolerated, dose reduction may be considered (see “4. Discontinuation”). 2. Epilepsy Adults: This medicine may be administered at an initial dose of 150 mg daily. Based on the individual patient's response and tolerability, the dose may be increased to 300 mg daily after 1 week. If necessary, it may thereafter be increased at 7-day intervals to a maximum of 600 mg daily. 3. Fibromyalgia The recommended dose of this medicine for fibromyalgia is 300 mg ~ 450 mg daily. Start with 75 mg twice daily (150 mg daily); based on efficacy and tolerability, the dose may be increased within 1 week to 150 mg twice daily (300 mg daily). For patients who do not experience sufficient benefit at a dose of 300 mg daily, the dose may be increased within 1 week to 225 mg twice daily (450 mg daily). Clinical studies were also conducted at a dose of 600 mg daily; however, there is no evidence of additional benefit or adequate tolerability at this dose. In view of dose-dependent adverse reactions, doses exceeding 450 mg daily are not recommended. 4. Discontinuation Based on current clinical experience, when discontinuing this medicine, it should be tapered gradually over at least 1 week. 5. Patients with renal impairment After entering the systemic circulation, this medicine is primarily excreted unchanged by the kidneys. Clearance of this medicine is directly affected by creatinine clearance; therefore, dose reduction in patients with impaired renal function should be individualized based on creatinine clearance. Creatinine clearance [Table 1] is determined using the following formula. *: For women, multiply the result obtained from the above equation by 0.85. This medicine is effectively removed from plasma by hemodialysis (approximately 50% within 4 hours). In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose based on renal function, an additional supplemental dose should be administered immediately after each 4-hour hemodialysis session. [Table 1]. Pregabalin dosing based on renal function Creatinine clearance (CLcr), (mL/min) / Total daily dose of pregabalin a / Administration / Starting dose (mg/day) / Maximum dose (mg/day) ≥60 / 150 / 600 / BID or TID ≥30 -<60 / 75 / 300 / BID or TID ≥15 -<30 / 25-50 / 150 / QD or BID <15 / 25 / 75 / QD Supplemental dose after hemodialysis / 25 / 100 / Single dose b TID = total daily dose administered in 3 divided doses BID = total daily dose administered in 2 divided doses QD = administered once daily a: The total daily dose (mg/day) should be divided as specified under Administration. b: Supplemental dose refers to an additional dose administered once. 6. Patients with hepatic impairment No dose adjustment is necessary in patients with hepatic impairment. 8. Elderly patients (65 years and older) Dose reduction may be necessary in elderly patients with impaired renal function.
Children under 12 years of age: Use is not recommended because there are insufficient safety and efficacy data. Adolescent patients aged 12 to 17 years: Use is not recommended because there are insufficient safety and efficacy data.
This medication may increase the risk of suicidal thoughts or behaviors, so any changes in mood or behavior should be carefully monitored during treatment. Do not use if you are allergic to any ingredients in this medication, and patients with certain genetic conditions like lactose intolerance should also avoid it. Diabetic patients may need to adjust the dosage of their blood sugar-lowering medications due to weight gain after using this medication. If symptoms of angioedema such as swelling of the face or neck occur, discontinue use immediately. Elderly patients should be cautious as this medication may increase the risk of dizziness or drowsiness, leading to a higher risk of falls. This medication may temporarily blur vision or cause changes in vision; consult a doctor if these symptoms occur. Abruptly stopping this medication may result in withdrawal symptoms such as insomnia, headache, or anxiety; it should be tapered according to a doctor's instructions. Because of the risk of drug abuse, patients with a history of mental health issues should be particularly cautious, and any signs of abuse should be reported to healthcare personnel immediately. Patients with heart disease or congestive heart failure should use this medication cautiously. Using this medication in conjunction with opioid analgesics may enhance CNS depressant effects, leading to risks such as difficulty breathing. Pregnant women should avoid this medication during early pregnancy due to the risk of fetal malformations, and women of childbearing potential should use effective contraception. Breastfeeding women should consult a doctor before taking this medication, as it may transfer to breast milk and affect the baby. It is advisable to avoid activities requiring concentration, such as driving or operating dangerous machinery, until dizziness or drowsiness has subsided after taking this medication. In cases of overdose, symptoms such as confusion, drowsiness, or depression may occur, and treatment such as dialysis may be necessary if required. This medication should be stored out of reach of children and should not be transferred to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to avoid exposure to air or moisture. Additionally, it is best to keep it in a location that avoids extreme temperatures, maintaining a room temperature between 15 to 30 degrees Celsius.
A hard capsule with a reddish-brown upper part and a white lower part containing white powder that is white or light yellow in color.
30 capsules/bottle, 60 capsules/bottle, 100 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Pregabalin 75mg
Hard capsule · Prescription medication
TDS Pharm Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.